1. Home
  2. UP vs NTLA Comparison

UP vs NTLA Comparison

Compare UP & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UP
  • NTLA
  • Stock Information
  • Founded
  • UP 2013
  • NTLA 2014
  • Country
  • UP United States
  • NTLA United States
  • Employees
  • UP N/A
  • NTLA N/A
  • Industry
  • UP Aerospace
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • UP Consumer Discretionary
  • NTLA Health Care
  • Exchange
  • UP Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • UP 1.4B
  • NTLA 1.2B
  • IPO Year
  • UP N/A
  • NTLA 2016
  • Fundamental
  • Price
  • UP $1.91
  • NTLA $20.36
  • Analyst Decision
  • UP
  • NTLA Buy
  • Analyst Count
  • UP 0
  • NTLA 19
  • Target Price
  • UP N/A
  • NTLA $30.47
  • AVG Volume (30 Days)
  • UP 9.6M
  • NTLA 6.9M
  • Earning Date
  • UP 11-06-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • UP N/A
  • NTLA N/A
  • EPS Growth
  • UP N/A
  • NTLA N/A
  • EPS
  • UP N/A
  • NTLA N/A
  • Revenue
  • UP $765,885,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • UP $174.46
  • NTLA $9.20
  • Revenue Next Year
  • UP N/A
  • NTLA N/A
  • P/E Ratio
  • UP N/A
  • NTLA N/A
  • Revenue Growth
  • UP N/A
  • NTLA 14.99
  • 52 Week Low
  • UP $0.74
  • NTLA $5.90
  • 52 Week High
  • UP $3.50
  • NTLA $21.49
  • Technical
  • Relative Strength Index (RSI)
  • UP 45.88
  • NTLA 75.10
  • Support Level
  • UP $1.71
  • NTLA $15.44
  • Resistance Level
  • UP $2.15
  • NTLA $21.49
  • Average True Range (ATR)
  • UP 0.21
  • NTLA 1.46
  • MACD
  • UP -0.03
  • NTLA 0.39
  • Stochastic Oscillator
  • UP 18.50
  • NTLA 86.28

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: